Jack W. Callicutt, CFO of Galectin Therapeutics ($GALT), sold nearly $1 million in company shares across 20 open market transactions over the past year. His latest sale occurred on January 6, 2026. These sales rank him 4,951st out of 11,678 insiders by total value sold, well below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | A | Stock option (right to buy) | 65000 | $0.00 | 65,000.0000 | 63,180,491 | 9999.99% | 0.10% |
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 63,180,491 | 9999.99% | 0.16% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 13914 | $4.20 | 53,700.0000 | 63,180,491 | 20.58% | 0.02% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common Stock | 60000 | $0.00 | 67,614.0000 | 63,180,491 | 788.02% | 0.09% |
| Jan. 6, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 20354 | $3.67 | 7,614.0000 | 63,180,491 | 72.78% | 0.03% |
| Jan. 5, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 25732 | $3.90 | 27,968.0000 | 63,180,491 | 47.92% | 0.04% |
| Jan. 1, 2026 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Restricted Stock Unit | 60000 | $0.00 | 0.0000 | 63,180,491 | 100.00% | 0.09% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 9586 | $1.98 | 17,200.0000 | 63,180,491 | 125.90% | 0.02% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 28120 | $0.00 | 0.0000 | 63,180,491 | 100.00% | 0.04% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 2323 | $0.00 | 48,750.0000 | 63,180,491 | 4.55% | 0.00% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 19701 | $0.00 | 18,190.0000 | 63,180,491 | 51.99% | 0.03% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 9586 | $0.00 | 28,120.0000 | 63,180,491 | 25.42% | 0.02% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 18210 | $6.22 | 7,614.0000 | 63,180,491 | 70.52% | 0.03% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock (right to buy) | 18190 | $0.00 | 0.0000 | 63,180,491 | 100.00% | 0.03% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 18210 | $1.11 | 25,824.0000 | 63,180,491 | 239.16% | 0.03% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 28100 | $6.22 | 7,614.0000 | 63,180,491 | 78.68% | 0.04% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 28100 | $1.98 | 35,714.0000 | 63,180,491 | 369.06% | 0.04% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 2323 | $6.03 | 7,614.0000 | 63,180,491 | 23.38% | 0.00% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 2323 | $1.23 | 9,937.0000 | 63,180,491 | 30.51% | 0.00% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 19701 | $6.03 | 7,614.0000 | 63,180,491 | 72.13% | 0.03% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 19701 | $1.11 | 27,315.0000 | 63,180,491 | 258.75% | 0.03% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 9586 | $6.03 | 7,614.0000 | 63,180,491 | 55.73% | 0.02% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 1880 | $1.98 | 9,694.0000 | 63,180,491 | 24.06% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 1675 | $1.11 | 9,289.0000 | 63,180,491 | 22.00% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 1736 | $0.00 | 51,073.0000 | 63,180,491 | 3.29% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 1675 | $0.00 | 37,891.0000 | 63,180,491 | 4.23% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 1880 | $0.00 | 37,706.0000 | 63,180,491 | 4.75% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 1736 | $6.03 | 7,614.0000 | 63,180,491 | 18.57% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 1736 | $1.23 | 9,350.0000 | 63,180,491 | 22.80% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 1675 | $6.03 | 7,614.0000 | 63,180,491 | 18.03% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 1880 | $6.02 | 7,614.0000 | 63,180,491 | 19.80% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 200 | $0.00 | 39,586.0000 | 63,180,491 | 0.50% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 200 | $1.98 | 7,814.0000 | 63,180,491 | 2.63% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 200 | $6.00 | 7,614.0000 | 63,180,491 | 2.56% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 200 | $1.11 | 7,814.0000 | 63,180,491 | 2.63% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 200 | $6.00 | 7,614.0000 | 63,180,491 | 2.56% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 200 | $1.72 | 7,814.0000 | 63,180,491 | 2.63% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 200 | $6.00 | 7,614.0000 | 63,180,491 | 2.56% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 200 | $0.00 | 39,566.0000 | 63,180,491 | 0.50% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 200 | $0.00 | 52,809.0000 | 63,180,491 | 0.38% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common Stock | 1300 | $1.98 | 8,914.0000 | 63,180,491 | 17.07% | 0.00% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 10741 | $0.00 | 53,009.0000 | 63,180,491 | 16.85% | 0.02% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 8974 | $0.00 | 39,766.0000 | 63,180,491 | 18.41% | 0.01% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 8914 | $0.00 | 39,786.0000 | 63,180,491 | 18.30% | 0.01% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 1250 | $0.00 | 63,750.0000 | 63,180,491 | 1.92% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 1260 | $0.00 | 48,740.0000 | 63,180,491 | 2.52% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 1300 | $0.00 | 48,700.0000 | 63,180,491 | 2.60% | 0.00% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 10741 | $6.07 | 7,614.0000 | 63,180,491 | 58.52% | 0.02% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 10741 | $1.72 | 18,355.0000 | 63,180,491 | 141.07% | 0.02% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 8974 | $6.07 | 7,614.0000 | 63,180,491 | 54.10% | 0.01% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 8974 | $1.11 | 16,588.0000 | 63,180,491 | 117.86% | 0.01% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common stock | 8914 | $6.07 | 7,614.0000 | 63,180,491 | 53.93% | 0.01% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common stock | 8914 | $1.98 | 16,528.0000 | 63,180,491 | 117.07% | 0.01% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Commno stock | 1250 | $6.01 | 7,614.0000 | 63,180,491 | 14.10% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common Stock | 1250 | $1.72 | 8,864.0000 | 63,180,491 | 16.42% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 1260 | $6.01 | 7,614.0000 | 63,180,491 | 14.20% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common Stock | 1260 | $1.11 | 8,874.0000 | 63,180,491 | 16.55% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 1300 | $6.01 | 7,614.0000 | 63,180,491 | 14.58% | 0.00% |
| Sept. 12, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 8706 | $6.44 | 7,614.0000 | 63,180,491 | 53.35% | 0.01% |
| Sept. 12, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Stock option (right to buy) | 8706 | $1.37 | 0.0000 | 63,180,491 | 100.00% | 0.01% |
| Sept. 12, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common Stock | 8706 | $1.37 | 16,320.0000 | 63,180,491 | 114.34% | 0.01% |
| Jan. 23, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | A | Restricted Stock Unit | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Restricted Stock Units | 40000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | S | Common Stock | 40000 | $0.89 | 7,614.0000 | 0 | 84.01% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | M | Common Stock | 40000 | $0.00 | 47,614.0000 | 0 | 525.35% | 0.00% |
| Jan. 24, 2024 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | GALECTIN THERAPEUTICS INC | $GALT | CALLICUTT JACK W | Chief Financial Officer | A | Restricted Stock Unit | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |